NEW YORK ( TheStreet) -- CHANGE IN RATINGSGroupon ( GRPN) upgraded at Morgan Stanley from Equal-weight to Overweight, Morgan Stanley said. $14 price target. Company can expand its domestic turnaround into the international market. HSN ( HSNI) upgraded at Citi from Neutral to Buy, Citigroup said. $67 price target. Fears of a Liberty tender have been overblown. Louisiana-Pacific ( LPX) upgraded at DA Davidson from Neutral to Buy, DA Davidson said. $20 price target. Ainsworth transaction should add to earnings.
Allscripts ( MDRX) rated new Hold at Keybanc. Company has a new management team, which still needs to prove its worth to investors. Omnicom ( OMC) upgraded at Lazard from Neutral to Buy, Lazard Capital Markets said. $78 price target. Stock is attractive, following a 12% pullback. OpenTable ( OPEN) downgraded at Morgan Stanley from Equal-weight to Underweight, Morgan Stanley said. Valuation call, based on a $60 price target. Transocean ( RIG) upgraded at Credit Suisse from Neutral to Outperform, Credit Suisse said. $60 price target. Stock appears washed out at current levels. Trimble Navigation ( TRMB) rated new Outperform at Baird. $36 price target. Company is addressing expanding global demand for mobile automation. Zillow ( Z) downgraded at Morgan Stanley from Equal-weight to Underweight, Morgan Stanley said. $70 price target. Have concerns about saturation of the total addressable market.
Broadcom ( BRCM) numbers cut at Jefferies. Shares of BRCM now seen reaching $34, Jefferies said. Estimates also lowered on higher OpEx associated with Renesas acquisition. Buy rating. Broadcom estimates, target cut at BMO. Shares of BRCM now seen reaching $27, according to BMO Capital. Estimates also reduced, as the Renesas acquisition could cut into earnings. Market Perform rating. Ciena ( CIEN) estimates, target raised at UBS. Shares of CIEN now seen reaching $24, according to UBS. Estimates also increased, given the strong spending cycle. Neutral rating. Dollar General ( DG) numbers increased at BMO. DG estimates were raised through 2014, BMO Capital said. Company is seeing higher same-store sales growth. Outperform rating and new $69 price target. Humana ( HUM) price target increased at JPMorgan to $110, JPMorgan said. Risk/reward remains compelling and Medicare Advantage sentiment has improved. Overweight rating. Verint ( VRNT) estimates, target boosted at Credit Suisse. Shares of VRNT now seen reaching $38, according to Credit Suisse. Estimates also upped, given solid sales execution and market share gains. Neutral rating.